IFNA1 and cancer: Although the use of IFN for cancer treatment has decreased due to its related adverse effects and the advent of more effective targeted therapies, IFN-I exerts an important role in regulating cancer progression through the activation of antitumor immune responses and may serve as prognostic or therapeutic predictor biomarker in different cancers and therapeutic modalities (52).